Topics

FDA Approves Sanofi’s Dengue Prevention Vaccine Dengvaxia in Narrower Patient Population

10:40 EDT 2 May 2019 | Genetic Engineering News

Twenty-six years after it began development, Sanofi’s dengue prevention vaccine Dengvaxia® (Dengue Tetravalent Vaccine, Live) has won FDA approval—albeit in a narrower patient population than what the pharma giant originally envisioned. Dengvaxia won FDA authorization as the first vaccine approved for the prevention of dengue disease caused by all dengue virus serotypes (1, 2, 3, […]

The post FDA Approves Sanofi’s Dengue Prevention Vaccine Dengvaxia in Narrower Patient Population appeared first on GEN - Genetic Engineering and Biotechnology News.

Original Article: FDA Approves Sanofi’s Dengue Prevention Vaccine Dengvaxia in Narrower Patient Population

NEXT ARTICLE

More From BioPortfolio on "FDA Approves Sanofi’s Dengue Prevention Vaccine Dengvaxia in Narrower Patient Population"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Tropical Medicine
Tropical Medicine is the study of diseases more commonly found in tropical regions than elsewhere. Examples of these diseases are malaria, yellow fever, Chagas disease, Dengue, Helminths, African trypanosomiasis, Leishmaniasis, Leprosy, Lymphatic filaria...